Global Medical REIT Inc.
GMRE · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $138 | $141 | $137 | $116 |
| % Growth | -1.8% | 2.7% | 18.4% | – |
| Cost of Goods Sold | $29 | $28 | $25 | $15 |
| Gross Profit | $109 | $113 | $112 | $100 |
| % Margin | 78.9% | 80.1% | 81.6% | 86.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $21 | $17 | $17 | $16 |
| SG&A Expenses | $21 | $17 | $17 | $16 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $55 | $58 | $57 | $47 |
| Operating Expenses | $76 | $75 | $73 | $63 |
| Operating Income | $33 | $38 | $39 | $37 |
| % Margin | 23.6% | 26.9% | 28.2% | 31.9% |
| Other Income/Exp. Net | -$26 | -$16 | -$19 | -$19 |
| Pre-Tax Income | $7 | $22 | $20 | $18 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $7 | $21 | $19 | $18 |
| % Margin | 4.8% | 14.6% | 14% | 15.2% |
| EPS | 0.31 | 5.75 | -2 | -0.855 |
| % Growth | -94.6% | 387.5% | -133.9% | – |
| EPS Diluted | 0.31 | 5.75 | -2 | -0.855 |
| Weighted Avg Shares Out | 3 | 3 | 3 | 2 |
| Weighted Avg Shares Out Dil | 3 | 3 | 3 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $29 | $31 | $25 | $20 |
| Depreciation & Amortization | $56 | $59 | $58 | $47 |
| EBITDA | $91 | $112 | $103 | $85 |
| % Margin | 66.1% | 79.2% | 75% | 73.7% |